XBP1 and Parkinson disease: Finally, mounting evidence suggests that Ire1/Xbp1 activity is highly correlated with the pathophysiology observed in neurodegenerative disorders in animal models, including Alzheimer’s, Parkinson’s and Huntington’s diseases, and age-associated decline in the activation of this pathway may be associated with disease progression47–49.